Wendell et al v. Johnson & Johnson et al
Filing
176
ORDER Granting 175 Stipulation FOR ORDER EXTENDING TIME. Signed by Judge Claudia Wilken on 6/23/2011. (ndr, COURT STAFF) (Filed on 6/23/2011)
1
3
Kevin Haverty, Esq., pro hac vice
WILLIAMS CUKER BEREZOFSKY, LLC
210 Lake Drive East, Suite 101
Cherry Hill, NJ 08002
Telephone: (856) 667-0500
4
Attorneys for Plaintiffs
2
5
6
7
8
UNITED STATES DISTRICT COURT
9
NORTHERN DISTRICT OF CALIFORNIA
10
OAKLAND DIVISION
11
12
13
STEPHEN WENDELL AND LISA WENDELL,
for themselves and as successors in interest to
MAXX WENDELL, DECEASED,
14
15
16
17
18
19
20
CASE NO. 4:09-CV-04124-CW
STIPULATED REQUEST FOR ORDER
EXTENDING TIME AND ORDER
Plaintiffs,
v.
JOHNSON & JOHNSON; CENTOCOR, INC.;
ABBOTT LABORATORIES; SMITHKLINE
BEECHAM d/b/a GLAXOSMITHKLINE; TEVA
PHARMACEUTICALS USA; GATE
PHARMACEUTICALS, a division of TEVA
PHARMACEUTICALS USA; PAR
PHARMACEUTICAL, INC.;
Removal Filed: September 4, 2009
Defendants.
21
22
23
24
25
26
27
28
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER
CASE NO. 4:09-CV-04124-CW
1
STIPULATION
2
3
4
Pursuant to Rule 6-2(a), the parties jointly request that the deadlines be extended as set forth
herein.
On September 4, 2009, this case was removed to the United States District Court for the
5
Northern District of California. A series of motions resolved multiple pleadings issues at the outset
6
of this litigation. On June 10, 2010 plaintiffs filed the operative amended Complaint and the
7
defendants all filed Answers on July 1, 2010. Discovery beyond initial disclosures began once
8
pleadings issues were resolved.
9
10
In the interim, the court, on June 3, 2010, entered a Case Management Order which provided,
among other things, that fact discovery was to end on February 2, 2011.
11
On July 13, 2010, plaintiffs served interrogatories and requests for production of documents
12
on all defendants. Defendants served responses to those discovery requests variously on August 25,
13
2010 (Centocor), September 24, 2010 (Par Pharmaceutical and Teva), October 4, 2010 (Abbott
14
Laboratories) and November 15, 2010 (GlaxoSmithKline). Defendants indicated that responsive
15
documents would be provided or made available for inspection and copying subject to the entry of a
16
protective order.
17
On July 28, 2010, plaintiffs’ counsel sent an email to counsel for defendant Abbott
18
Laboratories asking her to identify 30(b)(6) witnesses for deposition, Exhibit 1, to which she
19
responded the next day that Abbott would endeavor to identify the appropriate witnesses. Exhibit 2.
20
In Abbott’s responses to plaintiffs’ discovery requests, various witnesses with knowledge are
21
identified but Plaintiffs state that their depositions cannot be properly conducted until the underlying
22
documents have been reviewed.
23
On or about December 20, 2010, the Court granted the parties’ request to extend the deadline
24
to conduct mediation to June 29, 2011. On or about February 3, 2011, the Court granted the parties’
25
request to extend the discovery end date until June 30, 2011, and ordered that Plaintiffs designate
26
testifying experts and provide related reports by August 12, 2011, Defendants designate testifying
27
experts and provide related reports by October 30, 2012 [sic], the parties complete expert discovery
28
1
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER
CASE NO. 4:09-CV-04124-CW
1
on or before December 14, 2011, and dispositive motions be heard on or before (and a case
2
management conference would be set for) January 26, 2012. The trial date was not continued.
3
A protective order was ultimately entered by the Court on April 19, 2011. Thereafter,
4
Defendants collectively produced millions of pages of documents on disk drives to Plaintiffs. These
5
productions occurred variously on April 19 (Centocor) and May 11, 18 and 24, 2011 (Abbott).
6
Defendants GlaxoSmithKline, Teva and Par have offered to make documents available for
7
inspection and copying in response to Plaintiffs’ requests. Defendant Centocor has offered to make
8
available for inspection and copying its hard-copy production.
9
The parties have completed key depositions in this litigation, such as the deposition of Maxx
10
Wendell’s prescribing physician on April 11, 2011, and of Plaintiffs and another family member on
11
June 14, 2011. On several occasions, the last of which occurred on June 16, 2011, the parties
12
conferred about issues related to timing of mediation, potential dispositive motion practice, and
13
further discovery.
14
The parties have agreed to mediate this case with Honorable Rebecca Westerfield. The
15
parties are attempting to identify a mutually agreeable date in August but will, in any event, schedule
16
the mediation to occur on or before September 15, 2011. The parties believe that a stay of
17
discovery until after the mediation or, if the mediation is unsuccessful, until after the ruling on the
18
motions for summary judgment discussed below, will allow the parties to conserve resources for
19
settlement, conserve judicial resources, and help resolve the litigation.
20
Defendants plan to file motions for summary judgment based on the learned intermediary
21
doctrine. Defendants do not need additional discovery to file such motions. Plaintiffs have
22
conducted all discovery needed to oppose such motions and do not plan to oppose the motion on the
23
grounds that further discovery is necessary.
24
Should those motions and the mediation be unsuccessful, some additional fact discovery
25
would need to be conducted by the parties. Plaintiffs would need to conduct additional discovery
26
bearing on the issues of the adequacy of the warning labels which will not only involve reviewing
27
and selecting pertinent documents from the electronic discovery provided by Defendants but also
28
2
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER
CASE NO. 4:09-CV-04124-CW
1
conduct depositions pursuant to Fed. R. Civ. P. 30(b)(6). If they have not already done so, Plaintiffs
2
will supplement their responses to Defendants’ written discovery requests by providing (1) a list of
3
the categories of damages they seek and amounts for each and (2) certain responsive documents
4
Plaintiffs testified were available but which have not yet been produced to Defendants. Further fact
5
discovery to be conducted by Defendants includes taking additional depositions of at least two of
6
Maxx Wendell’s treating oncologists1 and any discovery arising from Plaintiffs’ responses to written
7
discovery previously propounded by Defendants.
8
THE PARTIES HEREBY STIPULATE AS FOLLOWS:
9
1.
10
The parties hereto request that the June 29, 2011 deadline for the parties to conduct
private mediation be continued to September 15, 2011.
11
2.
The parties request that all other deadlines be vacated.
12
3.
The parties request that discovery be stayed until after the mediation or ruling on
13
defendants’ motions for summary judgment, whichever comes later; at that time the parties will meet
14
and confer to determine a proposed schedule for remaining fact discovery listed above, expert
15
discovery, other pre-trial deadlines, and a new trial date.
16
4.
The parties will file a proposed scheduling order within two weeks of the mediation
17
(in the event it is unsuccessful) or ruling on defendants’ motions for summary judgment, whichever
18
comes later.
19
//
20
//
21
//
22
//
23
//
24
//
25
//
26
//
27
28
1
These depositions were previously scheduled for June 24, 2011. The parties would like to continue these depositions to
after the mediation to avoid incurring potentially unnecessary costs.
3
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER
CASE NO. 4:09-CV-04124-CW
1
5.
DECLARATION PURSUANT TO L.R. 6-2(a): The parties declare that (1) the
2
reason for the requested enlargement of time is to allow the parties to engage in mediation, potential
3
early dispositive motion practice and additional discovery should mediation or motion practice fail
4
to dispose of the case; (2) as set forth above, the parties anticipate that this modification of the
5
discovery end date will affect other deadlines including the April 2012 trial date.
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
DATED:
June 22, 2011
/s/ Kevin Haverty
Kevin Haverty (pro hac vice)
WILLIAMS CUKER BEREZOFSKY,
LLC
Woodland Falls Corporate Park
210 Lake Drive East, Suite 101
Cherry Hill, NJ 08002
Counsel for Plaintiffs
/s/ Andrew P. Bautista
Andrew P. Bautista (pro hac vice)
KIRKLAND & ELLIS LLP
300 North LaSalle
Chicago, Illinois 60654
Counsel for Abbott Laboratories
/s/ Michelle A. Childers
Michelle A. Childers
DRINKER BIDDLE & REATH LLP
50 Freemont Street, 30th Fl.
San Francisco, CA 94105
Counsel for Centocor Ortho Biotech, Inc.
and Johnson & Johnson
/s/ Prentiss W. Hallenbeck, Jr.
Prentiss W. Hallenbeck, Jr. (pro hac vice)
ULMER & BERNE LLP
600 Vine Street, Suite 2800
Cincinnati, OH 45202
Counsel for Teva Pharmaceuticals
USA, Inc.
/s/ William A. Hanssen
William A. Hanssen
DRINKER BIDDLE & REATH LLP
333 South Grand Ave., Ste. 1700
Los Angeles, CA 90071-1504
Counsel for SmithKline Beecham
Corporation
d/b/a GlaxoSmithKline
/s/ Prentiss W. Hallenbeck, Jr.
Prentiss W. Hallenbeck, Jr. (pro hac vice)
ULMER & BERNE LLP
600 Vine Street, Suite 2800
Cincinnati, OH 45202
Counsel for Par Pharmaceutical, Inc.
22
PURSUANT TO STIPULATION, IT IS SO ORDERED. Defendants shall notice their motion on
the learned intermediary defense for not later than Jan. 26, 2012, and a case management conference
will be held on that date at 2 pm.
23
June 23
Dated: _________________, 2011
24
CLAUDIA WILKEN
United States District Judge
25
26
27
28
4
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER
CASE NO. 4:09-CV-04124-CW
1
ATTESTATION PURSUANT TO GENERAL ORDER 45
2
I, Kevin Haverty, am the ECF user whose ID and password are being used to file this
3
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER. In
4
compliance with General Order 45, X.B., I hereby attest that the following attorneys have concurred
5
in this filing: Andrew P. Bautista, counsel for Abbott Laboratories; Michelle A. Childers, counsel
6
for Centocor Ortho Biotech, Inc., and Johnson & Johnson; Prentiss W. Hallenbeck, Jr., counsel for
7
Teva Pharmaceuticals USA, Inc., and Par Pharmaceutical, Inc.; William A. Hanssen, counsel for
8
SmithKline Beecham Corporation.
/s/ Kevin Haverty
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
5
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER
CASE NO. 4:09-CV-04124-CW
1
2
CERTIFICATE OF SERVICE
I HEREBY CERTIFY that on June 22, 2011, I electronically filed the foregoing
3
STIPULATED REQUEST FOR ORDER EXTENDING TIME AND [PROPOSED] ORDER with
4
the Clerk of the Court using the CM/ECF system which will send notification of such filing to the
5
email addresses registered, as denoted on the Court’s Electronic Mail Notice List, and I hereby
6
certify that I have mailed a true and correct copy of the foregoing document via the United States
7
Postal Service to the non-CM/ECF participants listed below:
8
9
10
John D. Winter
Patterson, Belknap, Webb & Tyler LLP
1133 Avenue Of The Americas
New York, New York 10036-6710
Jeffrey F. Peck
Ulmer & Berne LLP
600 Vine Street, Suite 2800
Cincinnati, Ohio 45202
11
12
I declare under penalty of perjury under the laws of the United States that the foregoing is true and
13
correct.
14
DATED: June 22, 2011
15
By: s/ Kevin Haverty
16
Kevin Haverty, pro hac vice
WILLIAMS CUKER BEREZOFSKY, LLc
Khaverty@wcblegal.com
210 Lake Drive East, Suite 101
Cherry Hill, New Jersey 08002
Telephone: (856) 667-0500
Fax:
(856) 667-5133
17
18
19
20
21
22
23
24
25
26
27
28
1
CERTIFICATE OF SERVICE
CASE NO. 4:09-CV-04124-CW
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?